Scientists at the Wadsworth Center's Bacteriology Laboratory recently published findings characterizing the genetic features of a recently identified bacterial species associated with complex urinary tract infections and antimicrobial resistance. Antimicrobial resistance occurs when bacteria acquire the ability to survive exposure to drugs that would normally kill them or inhibit their growth. Resistance to carbapenems, often considered drugs of last resort, is especially concerning because it can severely limit treatment options. Carbapenem resistance is frequently mediated by carbapenemase enzymes encoded by genes that can spread between bacteria through mobile genetic elements. Carbapenemase genes are a major focus of surveillance efforts by the CDC-funding Antimicrobial Resistance Laboratory Network, for which the Wadsworth Center is the Northeast Regional Laboratory.
In collaboration with the Vermont Department of Health, Wadsworth Center scientists combined antimicrobial susceptibility testing with short- and long-read whole-genome sequencing to characterize two isolates of the recently described species Providencia hangzhouensis harboring three clinically important carbapenemase genes (blaNDM-1, blaKPC-2, and blaVIM-24). The isolates were recovered from epidemiologically linked patients with histories of complex urinary tract infections. Researchers also identified an identical copy of the plasmid carrying all three carbapenemase genes in Citrobacter freundii, providing genomic evidence of plasmid dissemination between bacterial species.
Published this month in Microbial Genomics, the study highlights the role of plasmids in the acquisition and dissemination of antimicrobial-resistance determinants. It also demonstrates the importance of combining short- and long-read sequencing to resolve complex resistance mechanisms, characterize plasmid epidemiology, and strengthen surveillance of emerging multidrug-resistant pathogens